ProstaLund signs distribution agreement for the UK market
ProstaLund AB has signed an exclusive distribution agreement with the British company iUrology.
In line with the stated strategy, after acquiring a substantial base in its home market, ProstaLund is now starting its internationalization outside the Nordic region with an initial agreement regarding a collaboration with the British company iUrology.
ProstaLund's product CoreFlow® - Soft Stent has been particularly interesting in view of the current pandemic as it can be used both for patients waiting for BPE surgery and in patients with acute urinary retention. In the evaluation and discussions with the English urologists, the entire portfolio has been presented and there is obviously a curiosity also for heat treatment with CoreTherm as well as for the Schelin catheter as a stand-alone product for local anesthesia of the prostate prior to BPH procedures other than CoreTherm.
Shakeel Osman, CEO iUrology, comments: “We have evaluated ProstaLund's products during the fall 2021. The dialogues we have had with urologists in England have been very positive and we see that ProstaLund's portfolio is of interest to the UK market. In the short-term Covid-19 bothers us, but we have high hopes as soon as the restrictions are eased.”
“This agreement is important for the future. It is unlikely that it will have a significant impact to our sales in 2022, but it gives us a good basis for the next few years.", says CEO Johan Wennerholm.
Glycorex Transplantation (GTAB B): Sluter avtal med distributör i Sydafrika
Som ett led i bolagets strategi för marknadsexpansion har bolaget idag signerat ett avtal med en distributör i Sydafrika. Distributören säljer idag ett ledande globalt varumärke för att bevara organ utanför kroppen och hålla dem i optimal kondition i vän...
Glycorex Transplantation (GTAB B): Concludes agreement with distributor in South Africa
As part of the company's strategy for market expansion, the company has today signed an agreement with a distributor in South Africa. Today, the distributor sells a leading global brand to preserve organs outside the body and keep them in optimal condition while awaiting transplantation. Glycoso...
Brighter extends the agreement with Erik Lissner as acting CEO with an agreement of permanent employment from June 16
"Erik is doing a great job and I am very happy that we have extended the agreement, which will be transformed into a permanent agreement this summer. Erik has extensive experience in the MedTech sector and has in a short time managed to push through the changes that are necessary to bring Brigh...
Brighter förlänger avtalet med Erik Lissner som tillförordnad VD med överenskommelse om fast anställning från 16 juni
”Erik gör ett jättebra jobb och jag är mycket glad att vi har förlängt avtalet som därefter kommer att övergå i ett fast avtal till sommaren. Erik har bred erfarenhet inom MedTech-sektorn och har på kort tid lyckats driva igenom de förän...